Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Changzhou Qianhong Biopharma Co Ltd
Cash from Investing Activities
Changzhou Qianhong Biopharma Co Ltd
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
|
Cash from Investing Activities
¥13.4m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Investing Activities
¥1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Investing Activities
-¥2.2B
|
CAGR 3-Years
-94%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Investing Activities
-¥188m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
38%
|
CAGR 10-Years
9%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Investing Activities
¥2.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
59%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Cash from Investing Activities
-¥81.9m
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Changzhou Qianhong Biopharma Co Ltd's Cash from Investing Activities?
Cash from Investing Activities
13.4m
CNY
Based on the financial report for Mar 31, 2024, Changzhou Qianhong Biopharma Co Ltd's Cash from Investing Activities amounts to 13.4m CNY.
What is Changzhou Qianhong Biopharma Co Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
-36%
The average annual Cash from Investing Activities growth rates for Changzhou Qianhong Biopharma Co Ltd have been -59% over the past three years , -36% over the past five years .